Gevo, Inc. (NASDAQ: GEVO), a developer and manufacturer of renewable chemicals and biofuels, is coming public today. The initial public offering was for 7.15 million shares at $15.00 per share, making this one price at the top of its price range. Last week we had the share sale pegged at 7,150,000 shares of common stock with a price range of $13 to $15 per share.
The good news for this IPO is that all shares are being sold by the company itself. The net proceeds from this offering are expected to be $95.7 million. UBS, Piper Jaffray, and Citi were listed as the joint book-running managers; and Simmons & Company was the co-manager for the offering.
Gevo is developing capital efficient biorefinery systems to provide renewable and cost-effective building block products to the fuel and chemical industries. It converts renewable raw materials into isobutanol and renewable hydrocarbons that can be directly integrated into existing fuel and chemical products to deliver environmental and economic benefits.
The company plans to use the net proceeds of the IPO to acquire access to ethanol facilities through direct acquisition and joint ventures, and retrofit those facilities to produce isobutanol. For all practical purposes, the company is still in the pre-revenue stage as far as full-line operations are concerned.
JON C. OGG
Smart Investors Are Quietly Loading Up on These “Dividend Legends”
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
